Case Report
A case of unilateral epidermal nevi complicated by atopic dermatitis treated with dupilumab
Downloads
- Download
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.
License
Trends in Immunotherapy (TI) publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.
Epidermal Nevus Syndrome (ENS) is a congenital disorder characterized by skin lesions called epidermal nevi. This condition typically appears at birth or in infancy. However, a case of adult‐onset epidermal nevi was reported in a 36‐year‐old male with a history of atopic dermatitis (AD) and skin abnormalities on the right side of his body. He had been using topical steroids for AD but eventually started dupilumab treatment at age 41. The treatment led to significant improvements in his skin condition, including a reduction in erythema and scaling. Laboratory tests also showed improvement in serum Immunoglobulin E (IgE) levels and other markers. We report with a literature review.
Keywords:
atopic dermatitis epidermal nevi dupilumab unilateralReferences
- Kitayama N, Otsuka A, Kaku Y, et al. Case of unilateral epidermal nevi without extracutaneous anomalies. The Journal of Dermatology 2016; 43(10): 1241–1242. doi: 10.1111/1346-8138.13380
- Mizutani Y, Nagai M, Iwata H, et al. Epidermal nevus syndrome associated with dwarfism and atopic dermatitis. Children 2021; 8(8): 267. doi: 10.3390/children8080697
- Yuan T, Lu X, Tang B, et al. Differences in clinical characteristics and lesion proteomics between inflammatory linear verrucous epidermal nevus and local verrucous epidermal nevus. Journal of Proteomics 2022; 260: 104554. doi: 10.1016/j.jprot.2022.104554
- Nguyen JK, Austin E, Huang A, et al. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Archives of Dermatological Research 2020; 312: 81–92. doi: 10.1007/s00403-019-01972-3